12.04.2017
- Swiss pharmaceutical major Novartis has chosen to exercise an option to in-license an experimental eye drug from US biopharma Lubris. The drug, ECF843, is a recombinant human...
22.03.2017
- The US Food and Drug Administration (FDA) has approved Novartis’ new drug Kisqali (ribociclib) as an initial treatment for postmenopausal women with a type of metastatic breast...
27.02.2017
- The US Food and Drug Administration (FDA) has accepted Swiss pharmaceutical major Novartis’ supplemental New Drug Application (sNDA) for filing and granted priority review for the...
01.02.2017
- In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...
07.12.2016
- French drugs major Sanofi is weighing a rival offer to Johnson & Johnson’s recent bid for Swiss pharmaceuticals and biotech firm Actelion, the news agency Bloomberg has reported...
29.11.2016
- Major US healthcare company Johnson & Johnson (J&J) is holding preliminary talks with Swiss pharmaceuticals and biotechnology firm Actelion about a potential takeover. An...
10.11.2016
- Shares in major globally active pharmaceutical producers rose by as much as 11% on the news that Donald Trump had won the Nov. 8 election as president of the United States. The...
10.10.2016
- As part of a “broader, global strategic plan” to centralize control over its drug discovery programs and contain costs, Swiss drugmaker Novartis said it will close R&D sites in...
